Copyright
©The Author(s) 2020.
World J Transplant. May 29, 2020; 10(5): 117-128
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Table 6 mRNA expression levels of donor grafts with ≥ 30% macrosteatosis
Gene name | Accession number | Counts in ≥ 30% | Count in < 30% | Fold difference |
CCL20 | NM_004591.1 | 1,722 | 357 | +4.8 |
S100A12 | NM_005621.1 | 1,052 | 327 | +3.2 |
S100A8 | NM_002964.4 | 5,919 | 2,487 | +2.4 |
S100A9 | NM_002965.3 | 8,959 | 4,030 | +2.2 |
C3 | NM_000064.2 | 5,543 | 8,484 | -1.5 |
IGFBP1 | NM_000596.2 | 2,048 | 3,093 | -1.5 |
FN1 | NM_212482.1 | 1,833 | 2,736 | -1.5 |
CFB | NM_001710.5 | 8,096 | 11,359 | -1.4 |
CRP | NM_000567.2 | 33,132 | 45,455 | -1.4 |
- Citation: Núñez K, Hamed M, Fort D, Bruce D, Thevenot P, Cohen A. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation. World J Transplant 2020; 10(5): 117-128
- URL: https://www.wjgnet.com/2220-3230/full/v10/i5/117.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i5.117